These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 2848323

  • 1. Clinical effectiveness of defibrotide in vaso-occlusive disorders and its mode of actions.
    Ulutin ON.
    Semin Thromb Hemost; 1988; 14 Suppl():58-63. PubMed ID: 2848323
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM, Sartori MT, Viero ML, Scapinello MP, Boeri G, Girolami A.
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Defibrotide: an overview of clinical pharmacology and early clinical studies.
    Cornelli U, Nazzari M.
    Semin Thromb Hemost; 1988; 14 Suppl():64-70. PubMed ID: 3057638
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
    Evangelista V, Piccardoni P, de Gaetano G, Cerletti C.
    Thromb Haemost; 1992 Jun 01; 67(6):660-4. PubMed ID: 1509406
    [Abstract] [Full Text] [Related]

  • 17. Proceedings of the defibrotide symposium. 8th International Congress on Thrombosis. Istanbul, June 4-7, 1984.
    Haemostasis; 1986 Jun 01; 16 Suppl 1():1-68. PubMed ID: 3754832
    [No Abstract] [Full Text] [Related]

  • 18. [Defibrotide: a new antithrombotic agent].
    Bán A.
    Orv Hetil; 2001 Jun 03; 142(22):1193-4. PubMed ID: 11424595
    [No Abstract] [Full Text] [Related]

  • 19. Deficient fibrinolytic response in patients with Raynaud's phenomenon and its correction with defibrotide.
    Cimminiello C, Milani M, Pietra A, Rossi F, Aloisio M, Nazzari M, Bonfardeci G.
    Semin Thromb Hemost; 1991 Jun 03; 17 Suppl 1():106-11. PubMed ID: 2068563
    [Abstract] [Full Text] [Related]

  • 20. Defibrotide normalizes cardiovascular function hampered by established atherosclerosis in the rabbit.
    Rossoni G, Berti F, Trento F, Cattaneo F, Porta R, Pescador R, Ferro L.
    Thromb Res; 2000 Jan 15; 97(2):29-38. PubMed ID: 10688332
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.